Data as of Apr 17
| +0.16 / +0.53%|
The 18 analysts offering 12-month price forecasts for Pfizer Inc have a median target of 34.50, with a high estimate of 41.00 and a low estimate of 29.00. The median estimate represents a +14.05% increase from the last price of 30.25.
The current consensus among 21 polled investment analysts is to Buy stock in Pfizer Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.